STREPTOKINASE EFFICACY IN MYOCARDIAL INFARCTION MANAGEMENT: IS IT RELATED TO SERUM ANTISTREPTOKINASE ANTIBODY TITER

Introduction. Antistreptokinase antibodies in sera of individuals with previous streptococcal infection might theoretically influence the thrombolytic activity of streptokinase. Streptokinase as the only thrombolytic drug is used in MI management in Iran. Since, the prevalence of streptococcal infec...

Full description

Bibliographic Details
Main Authors: H SHEMIRANI, A REZAEI, S MATIN KHAH, F OREYZI
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2000-06-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://journals.mui.ac.ir/jrms/article/view/3516